Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 11:04 AM ET

Biotechnology

Company Overview of Regenxbio Inc.

Executive Profile

Allan M. Fox

Director and Member of Disclosure Committee, Regenxbio Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
67--

Background

Mr. Allan M. Fox has been a Partner of FoxKiser since 1986. Mr. Fox is the Founder of FoxKiser. He is specializing in identifying and enhancing business opportunities and improving competitive market position in the pharmaceutical and biotechnology industries. Before forming FOXKISER twenty-five years ago, Mr. Fox established the Washington office of the law firm of Kaye, Scholer, Fierman, Hays & Handler. Mr. Fox has been a Director of REGENX Biosciences, LLC (now ...

Corporate Headquarters

9712 Medical Center Drive
Rockville, Maryland 20850

United States

Phone: 240-552-8181
Fax: --

Board Members Memberships

2008-Present
Director and Member of Disclosure Committee

Education

JD
Temple University
BA
Temple University
Master's Degree
Yale Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
$650.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Regenxbio Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.